Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma

BACKGROUND: NC-6300 is a novel epirubicin (EPI) drug conjugated polymeric micelle developed using cutting-edge micellar nanoparticle technology. The nanoparticle epirubicin conjugates EPI to a polymer via a pH-sensitive linker which enables the selective EPI release into tumor. Tumor activity was ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedel, Richard F, Chua, Victoria, Moradkhani, Ania, Krkyan, Natalie, Ahari, Amir, Osada, Atsushi, Chawla, Sant P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526480/
https://www.ncbi.nlm.nih.gov/pubmed/35920783
http://dx.doi.org/10.1093/oncolo/oyac155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526480/
https://www.ncbi.nlm.nih.gov/pubmed/35920783
http://dx.doi.org/10.1093/oncolo/oyac155

Ejemplares similares